AliveCor
The not-yet-FDA-cleared device uses three electrodes to create a more detailed reading than existing consumer devices.
The announcement has drawn questions about novelty and claims of coziness with the FDA.
The KardiaK Software Platform could be used with mobile ECG devices to identify potential cases of kidney disease.
Digital health was a topic of discussion this week at the Heart Rhythm Society Scientific Sessions in Boston as researchers and clinicians from around the world presented their most recent study results.
Over the weekend AliveCor announced that its technology was validated in two studies.
Editor's note: The headline of a previous version of this article incorrectly referred to Omron's devices as heart rate monitors instead of blood pressure monitors.
Proteus Digital Health, which offers an ingestible sensor and digital medicine system, has hired Molly O’Neill as its chief commercial officer.
San Francisco-based AliveCor, which offers smartphone-enabled ECG devices, has announced former Google SVP Vic Gundotra as its new CEO.
The next generation of digital health offerings will use machine learning to treat patients more effectively, but it's still a decade away, according to Vinod Khosla, founder of Khosla Ventures, who spoke at Partners HealthCare's Connected Health Symposium in Boston this week.
It's been almost a year since AliveCor began offering its first FDA-cleared algorithm, its atrial fibrillation detection algorithm, to customers.